Pierre Charbonnier - Biomerieux Manufacturing Quality

All Insiders . France . 
Stock . Biomerieux SA . Stakeholders . Insider . Pierre Charbonnier
BIM Stock  EUR 96.50  1.00  1.03%   

Insider

Pierre Charbonnier is Manufacturing Quality of Biomerieux SA
Phone33 4 78 87 20 00
Webhttps://www.biomerieux.com

Biomerieux Management Efficiency

The company has return on total asset (ROA) of 0.1008 % which means that it generated a profit of $0.1008 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1751 %, meaning that it generated $0.1751 on every $100 dollars invested by stockholders. Biomerieux's management efficiency ratios could be used to measure how well Biomerieux manages its routine affairs as well as how well it operates its assets and liabilities.
Biomerieux SA has accumulated 362.8 M in total debt with debt to equity ratio (D/E) of 27.3, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Biomerieux SA has a current ratio of 1.68, which is within standard range for the sector. Debt can assist Biomerieux until it has trouble settling it off, either with new capital or with free cash flow. So, Biomerieux's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Biomerieux SA sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Biomerieux to invest in growth at high rates of return. When we think about Biomerieux's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Olivier RigaudyTeleperformance SE
64
Dev MudaliarTeleperformance SE
N/A
Luciana CemerkaTeleperformance SE
N/A
Julien TanguyEdenred SA
50
Piet WigerinckIpsen SA
54
Rajesh SaigalEurofins Scientific SE
N/A
Yannis TourcomanisTeleperformance SE
N/A
Virginie HeuzTeleperformance SE
N/A
Laurent LebrasEurofins Scientific SE
N/A
Eric SauvageEdenred SA
51
Agustin GrisantiTeleperformance SE
50
Gabriel JuliaEurofins Scientific SE
N/A
Joachim ReicheltEurofins Scientific SE
N/A
Daniel JulienTeleperformance SE
71
Leigh RyanTeleperformance SE
70
Solne ZammitoEdenred SA
N/A
Benedikt OrzelekSartorius Stedim Biotech
N/A
Philippe LopesFernandesIpsen SA
N/A
Alan WintersTeleperformance SE
N/A
David BryantEurofins Scientific SE
N/A
Petra KirchhoffSartorius Stedim Biotech
54
bioMrieux S.A. provides vitro diagnostic solutions systems for private and hospital laboratories, primarily for the diagnosis of infectious diseases. The company was formerly known as B-D Mrieux. bioMrieux S.A. was founded in 1963 and is based in Marcy lEtoile, France. bioMrieux S.A. is a subsidiary of Institut Mrieux SA. BIOMERIEUX operates under Diagnostics Research classification in France and is traded on Paris Stock Exchange. It employs 11200 people. Biomerieux SA (BIM) is traded on Euronext Paris in France and employs 12,084 people.

Management Performance

Return On Equity0.18
Return On Asset0.1

Biomerieux SA Leadership Team

Elected by the shareholders, the Biomerieux's board of directors comprises two types of representatives: Biomerieux inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Biomerieux. The board's role is to monitor Biomerieux's management team and ensure that shareholders' interests are well served. Biomerieux's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Biomerieux's outside directors are responsible for providing unbiased perspectives on the board's policies.
Frederic Beseme, Head CSR
Guillaume Bouhours, Ex CFO
Pierre Boulud, Chief Operations
Franois Lacoste, Ex RD
Mark Miller, Ex Affairs
Alexandre Merieux, Chairman CEO
Valerie Leylde, Communications HR
Sylvain Morgeau, Investor Relations
Pierre Charbonnier, Manufacturing Quality
Yasha Mitrotti, Ex Microbiology

Biomerieux Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Biomerieux a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity0.18
Return On Asset0.1
Profit Margin0.16 %
Operating Margin0.21 %
Current Valuation11.4 B
Shares Outstanding118.37 M
Shares Owned By Insiders64.28 %
Shares Owned By Institutions18.57 %
Price To Earning35.41 X
Price To Book3.27 X

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
RSIRush Street Interactive
OKTAOkta Inc
BACBank of America

Other Information on Investing in Biomerieux Stock

Biomerieux financial ratios help investors to determine whether Biomerieux Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Biomerieux with respect to the benefits of owning Biomerieux security.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY